Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
Phase II study of MEK inhibitor trametinib alone and in combination with AKT inhibitor GSK2141795/uprosertib in patients with metastatic triple negative breast cancer.
Journal: Breast cancer research and treatment
Published: July 27, 2024
TTF-1 Positive Primary Small Cell Carcinoma of the Breast: A Case Report and Review of the Literature.
Journal: Frontiers in endocrinology
Published: January 09, 2020
Showing 1-3 of 3
Last Updated: 09/26/2026